China Widens Drugmaker Probe as Glaxo Bribery Charges Outlined

China Widens Drugmaker Probe as Glaxo Bribery Charges Outlined

Simon Dawson/Bloomberg

A GlaxoSmithKline Plc logo sits on a sign outside the company's headquarters in London.